Keywords: Preclinical Image Analysis, Cancer
Motivation: Cancer cells undergo significant metabolic reprogramming to meet the demands of rapid proliferation, survival under stress, and development of treatment resistance. This metabolic heterogeneity presents a challenge for selecting effective therapies for individual patients.
Goal(s): A deeper understanding of these metabolic adaptions opens unique therapeutic pathways for cancer treatment.
Approach: In our study, we used hepatocellular carcinoma cell lines with different phenotypes and various targeted therapies to evaluate the effectiveness of 13C NMR spectroscopy towards identifying metabolic targets and assessing therapeutic efficacy.
Results: We demonstrate that 13C NMR spectroscopy can detect cellular metabolic profiles and monitor metabolic alterations during treatment.
Impact: Cancer cells undergo extensive metabolic reprogramming to support rapid proliferation, survival, and treatment resistance. 13C NMR spectroscopy can rapidly provide valuable insight into cellular metabolism and therapeutic efficacy, potentially enabling clinicians to provide more personalized cancer care.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords